Search research articles
Contact Us
Filters
Showing results (1-10 of 161) with videos related to
Page
of 17
Sort By:
Lancet (London, England)
|
May 16, 2015
Rheumatoid arthritis: biological drugs and risk of infection
William G Dixon
Annals of the Rheumatic Diseases
|
August 2, 2012
Understanding the side effects of glucocorticoid therapy: shining a light on a drug everyone thinks they know
William G Dixon, Nick Bansback
Best Practice & Research. Clinical Rheumatology
|
September 13, 2015
Risk of infection with biologic antirheumatic therapies in patients with rheumatoid arthritis
Manjari Lahiri, William G Dixon
Current Opinion in Rheumatology
|
January 26, 2018
Using technology to support clinical care and research in rheumatoid arthritis
William G Dixon, Kaleb Michaud
Best Practice & Research. Clinical Rheumatology
|
April 25, 2016
Corrigendum to "Risk of infection with biologic antirheumatic therapies in patients with rheumatoid arthritis" [Best Pract Res Clin Rheumatol 29 (2) (2015) 290-305]
Manjari Lahiri, William G Dixon
BMJ (Clinical Research Ed.)
|
December 8, 2017
Opioids are not just an American problem
Meghna Jani, William G Dixon
Arthritis and Rheumatism
|
February 10, 2011
Looking beyond incidence in the relationship between anti-tumor necrosis factor therapy and malignancy
Louise K Mercer, William G Dixon
Nature Reviews. Rheumatology
|
May 4, 2011
Bisphosphonates and esophageal cancer--a pathway through the confusion
William G Dixon, Daniel H Solomon
Best Practice & Research. Clinical Rheumatology
|
December 14, 2004
Does early rheumatoid arthritis exist?
William G Dixon, Deborah P M Symmons
Arthritis Research & Therapy
|
September 3, 2011
The association between systemic glucocorticoid therapy and the risk of infection in patients with rheumatoid arthritis: systematic review and meta-analyses
William G Dixon, Samy Suissa, Marie Hudson
Page
of 17
Search research articles
Search
Showing results (1-10 of 161) with videos related to
Sort By:
Page
of 17
Lancet (London, England)
|
May 16, 2015
Rheumatoid arthritis: biological drugs and risk of infection
William G Dixon
Annals of the Rheumatic Diseases
|
August 2, 2012
Understanding the side effects of glucocorticoid therapy: shining a light on a drug everyone thinks they know
William G Dixon, Nick Bansback
Best Practice & Research. Clinical Rheumatology
|
September 13, 2015
Risk of infection with biologic antirheumatic therapies in patients with rheumatoid arthritis
Manjari Lahiri, William G Dixon
Current Opinion in Rheumatology
|
January 26, 2018
Using technology to support clinical care and research in rheumatoid arthritis
William G Dixon, Kaleb Michaud
Best Practice & Research. Clinical Rheumatology
|
April 25, 2016
Corrigendum to "Risk of infection with biologic antirheumatic therapies in patients with rheumatoid arthritis" [Best Pract Res Clin Rheumatol 29 (2) (2015) 290-305]
Manjari Lahiri, William G Dixon
BMJ (Clinical Research Ed.)
|
December 8, 2017
Opioids are not just an American problem
Meghna Jani, William G Dixon
Arthritis and Rheumatism
|
February 10, 2011
Looking beyond incidence in the relationship between anti-tumor necrosis factor therapy and malignancy
Louise K Mercer, William G Dixon
Nature Reviews. Rheumatology
|
May 4, 2011
Bisphosphonates and esophageal cancer--a pathway through the confusion
William G Dixon, Daniel H Solomon
Best Practice & Research. Clinical Rheumatology
|
December 14, 2004
Does early rheumatoid arthritis exist?
William G Dixon, Deborah P M Symmons
Arthritis Research & Therapy
|
September 3, 2011
The association between systemic glucocorticoid therapy and the risk of infection in patients with rheumatoid arthritis: systematic review and meta-analyses
William G Dixon, Samy Suissa, Marie Hudson
Page
of 17